NIHR BioResource: Our contribution to COVID-19 research:
The COVID-19 BioResource was the response by our network and our partners at the emergence of the pandemic at the turn of 2020. Using our unique expertise in sample handling and our participant contributions, we have helped drive research into the genetics of COVID-19 and have already made a significant contribution to the international effort in this field.
"Our contribution to COVID-19 research" is a short video explaining the role of the BioResource in response to the pandemic. While most of our regular activity was curtailed back in March 2020, we quickly launched a COVID-19 BioResource, with now more than 8,000 participants registered to take part in research relating to the virus.
The video features our Director, Dr Nathalie Kingston, explaining why the BioResource is such a unique and powerful resource in health research and why we had to respond in the way we did when COVID-19 emerged.
We are delighted to include interviews with two University of Cambridge researchers, Professor Ravi Gupta and Dr Adam Abdullahi, who have used the COVID-19 BioResource in their research, and one of our wonderful volunteers, without whom this ground-breaking research wouldn’t be possible. Robert explains his motivations and experience of participating in health research by joining the BioResource.
We are recruiting four groups of people to the COVID-19 BioResource.
- those who have been diagnosed with COVID-19 and have been admitted to hospital, both in the wards and in the Intensive Care Units (ICU).
- those who have been diagnosed with COVID-19 but have mild symptoms
- those who have been diagnosed with COVID-19 but are asymptomatic (apparently no symptoms)
- those who are being or have been vaccinated
We are also interested in people joining the BioResource who have not been diagnosed with COVID-19. Take a look at Michael and Tish's story.
Our researchers have done a lot of very successful work following the phenotyping of patients over time and severity of disease. We are also keen to monitor vaccination responses.
If you are interested in taking part please see our Participants section for further information or contact us
Want to make a difference?
If you join us, you are helping to speed the progress of medical research. Every one of us makes a difference
We are a key partner in the GenOMICC study - a major new human whole genome sequencing study taking place across the UK National Health Service.
Currently, the genomes of people (currently or previously in an intensive care unit with coronavirus and those who have mild or moderate symptoms) are being analysed.
The ultimate aim is to develop a full catalogue of human genetic variation and COVID-19 by recruiting every single COVID-19 patient who admitted to intensive care in the UK.